Healthtech funding in August 2021
European Healthtech startup funding raised during August 2021.
In August 2021, 51 European Healthtech companies closed 51 funding rounds and raised €702M in equity funding (excluding debt and grants), up 104.6% versus August 2020. Debt rounds added €2.0M. UK led by capital raised, and Adage Capital Management was the most active investor. Data as of 20 Nov 2026.
Equity funding
€702M
+104.6% vs August 2020 · excl. debt & grants · +€2.0M debt
Funding rounds
51
+27.5% vs August 2020
Companies
51
Top country
UK
Rank among sectors
#7
4.7% of sector funding
Debt financing
€2.0M
0.3% of total
Top-10 round share
79.6%
of disclosed capital
Top countries
by € raisedHealthtech — top countries by capital, August 2021 — interactive chart.
Data table
| Healthtech — top countries by capital, August 2021 | |
|---|---|
| UK | €284M |
| Germany | €210M |
| France | €62M |
| Israel | €55M |
| Sweden | €49M |
| Iceland | €20M |
| Switzerland | €13M |
| Finland | €5.0M |
Stage mix
by € raisedHealthtech — stage mix, August 2021 — interactive chart.
Data table
| Healthtech — stage mix, August 2021 | |
|---|---|
| Series B | €313M |
| Other | €204M |
| Series A | €107M |
| Series C | €54M |
| Seed | €14M |
| Crowdfunding | €10M |
| Debt | €2.0M |
| Grant | €1.9M |
Exits & M&A
6 Acquisition6 exits · €175M disclosed.
| Zebra Medical Vision | Acquisition | Aug 2021 | €171M |
| Phasya | Acquisition | Aug 2021 | €4.0M |
Top deals
largest disclosed rounds in August 2021| Company | Stage | Date | Amount |
|---|---|---|---|
| Pepgen | Other | Aug 2021 | €95M |
| T-knife | Series B | Aug 2021 | €93M |
| Beckley Psytech | Series B | Aug 2021 | €68M |
| Cardior Pharmaceuticals | Series B | Aug 2021 | €64M |
| DnaNudge | Series A | Aug 2021 | €51M |
| Tissium | Series C | Aug 2021 | €50M |
| Anocca | Series B | Aug 2021 | €40M |
| Ottonova | Other | Aug 2021 | €40M |
| BrainQ | Other | Aug 2021 | €34M |
| Ultromics | Series B | Aug 2021 | €28M |
| EpiEndo Pharmaceuticals | Series A | Aug 2021 | €20M |
| SolasCure | Series A | Aug 2021 | €18M |
| Eyevensys | Series B | Aug 2021 | €10M |
| Hagar | Series B | Aug 2021 | €10.0M |
| BiVictriX | Other | Aug 2021 | €8.8M |
Top investors
most active in August 2021, by deal count- Adage Capital Management2 deals
- EPFL Tech Launchpad2 deals
- LSP2 deals
- OurCrowd2 deals
- Oxford Sciences Innovation2 deals
- RA Capital Management2 deals
- Swisshealth Ventures2 deals
- Verve Ventures2 deals
- 7percent Ventures1 deals
- ABC Ventures1 deals